Zymfentra® (infliximab-dyyb)
for Ulcerative Colitis

Zymfentra (infliximab-dyyb) is a tumor necrosis factor (TNF) blocker used to treat moderately to severely active Crohn’s disease or ulcerative colitis after IV infliximab induction therapy. As a subcutaneous (SC) injection, it can be self-administered at home. By blocking excess TNF, Zymfentra helps reduce inflammation and immune activity, providing symptom relief in these conditions.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Ulcerative Colitis - UC